Upcoming Hematology & Oncology CME Events

We are excited to announce that the Department of Internal Medicine Division of Hematology & Oncology and the Rogel Cancer Center are hosting three engaging Continuing Medical Education (CME) events this October and November 2024. These events reflect Michigan Medicine's steadfast commitment to continuous learning, innovation, and excellence in patient care.  

Annual Hematologic Malignancies Symposium - October 19

The Annual Hematologic Malignancies Symposium is intended for physicians, physicians in training (residents/fellows), medical students, pharmacists, and advanced practice providers in the field of malignant hematology.

After completing this activity, participants will be able to:

• Utilize current, state of the art updates in the diagnosis, risk stratification, and treatment of all hematologic malignancies.
• Enroll patients in the appropriate clinical trials designed specifically to treat hematologic malignancies.

There isn't a cost to attend; however, registration is required. Learn more and register.

General Anemias & Anticoagulation Management Seminar - November 2

The General Anemias & Anticoagulation Management webinar is a clinically focused program designed for primary care health providers who care for patients with anemia and who require anticoagulation therapy.

At the conclusion of this course, participants will be able to:

• Outline the treatment and management options available for iron deficiency anemia.
• Identify different methods used in the reversal of anticoagulation.
• Define different approaches to treat patients experiencing thrombosis.
• Assess the symptoms of hemolytic anemia and determine the tests needed to diagnose.

Learn more and register.

Inaugural Advanced Genitourinary Cancers Symposium - November 9

The Inaugural Advanced Genitourinary Cancers Symposium is intended for physicians, physicians in training (residents/fellows), medical students, pharmacists, and advanced practice providers in the field of advanced genitourinary cancers.

At the conclusion of this symposium, participants will be able to

• Utilize current state of the art updates in the diagnosis, risk stratification, and treatment of advanced (metastatic) genitourinary cancers including prostate, renal, bladder, and testis.
• Access information and enroll advanced genitourinary cancer patients in current groundbreaking clinical trials at Michigan Medicine.

There isn't a cost to attend; however, registration is required. Click here to register.

Additional CME Opportunities

The Department of Internal Medicine offers a number of innovative and evidence-based continuing medical education opportunities. View the Department of Internal Medicine CME Course Schedule.